iSirona - Medical Device Connectivity Solutions

Carl Witonsky has over 35 years of healthcare operational and venture capital experience. He previously was managing director of The Flying W Fund, a satellite group of St. Paul Venture Capital, where he focused on investments in healthcare information technology. Witonsky started his career in the healthcare sector with Shared Medical Systems (now Siemens) and since has served as chairman of the board of Integrated Medical Management, interim CEO of CliniComp, CEO of Medi-Code and chairman of the board of PACE Health Management. Currently, Witonsky serves on the board of Dairyland Healthcare Solutions and is chairman of the board of Sentillion.

Patrick Soon-Shiong, M.D.is Chairman of The Chan Soon-Shiong Family Foundation, the Executive Chairman and CEO of Abraxis Health and founder of The National Coalition for Health Integration. He is the Executive Director of the UCLA Wireless Health Institute, and Professor of Microbiology, Immunology, Molecular Genetics and Bioengineering at UCLA. Dr. Soon-Shiong is a fellow of the American College of Surgeons and the Royal College of Physicians and Surgeons of Canada. In 1993, he performed the world’s first encapsulated human islet transplant and the first pig to man islet cell transplant in diabetic patients. He invented the nation’s first FDA approved protein nanoparticle delivery technology for the treatment of metastatic breast cancer, now approved in over 38 countries, currently in trials for lung, melanoma, gastric and pancreatic cancer. He is a co-inventor of over 50 issued U.S. patents, has published more than 100 scientific papers, and founder of 2 multi-billion dollar pharmaceutical companies, American Pharma Partners (APP) and Abraxis Bioscience (ABII). APP was responsible for the only safe supply of Heparin in the United States in 2008, and ABII achieved the goal of the nation’s first FDA approved blood-derived nanoparticle for breast cancer, doubling the response rate in patients with metastatic disease.

Peter has more than 20 years of experience in business development and sales leadership in the healthcare industry. He previously served as director of business development for the Americas while at Metrologic, now part of Honeywell, and as VP of business development at Falcon Capital Partners. Peter also served as  senior account executive with McKesson and vice president of national accounts for Quovadx.

Dave has been CEO of iSirona since founding the company in 2008. Prior to iSirona, Dave was president and CEO of HCTSi/Noesis Health, a healthcare information technology consulting company he founded in 2004 that was successfully sold to a larger consultancy. Dave has over 21 years of experience in healthcare information technology and sales.